© 2005 Oxford University Press
ARTICLE |
A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients
Affiliations of authors: Centre de Recherche en Cancérologie de L'Université Laval (IB, FM, BT, FH) and the Centre Hospitalier Universitaire de Québec (AF, EV, JR), Québec City, Québec, Canada; the Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada (MG, PDV); the Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada (AN); the Complexe Hospitalier de la Sagamie, Saguenay, Québec, Canada (FB, SV); the Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada (J-PM); the Fred Hutchinson Cancer Research Center, Seattle, WA (BM)
Correspondence to: François Meyer, MD, DSc, Centre de Recherche en Cancérologie, Université Laval, 11 côte du Palais, Québec, Québec G1R 2J6, Canada (e-mail: francois.meyer{at}chuq.qc.ca).
Background: Although low dietary intakes of antioxidant vitamins and minerals have been associated with higher risks of cancer, results of trials testing antioxidant supplementation for cancer chemoprevention have been equivocal. We assessed whether supplementation with antioxidant vitamins could reduce the incidence of second primary cancers among patients with head and neck cancer. Methods: We conducted a multicenter, double-blind, placebo-controlled, randomized chemoprevention trial among 540 patients with stage I or II head and neck cancer treated by radiation therapy between October 1, 1994, and June 6, 2000. Supplementation with 
-tocopherol (400 IU/day) and 
-carotene (30 mg/day) or placebo began on the first day of radiation therapy and continued for 3 years after the end of radiation therapy. In the course of the trial, -carotene supplementation was discontinued after 156 patients had enrolled because of ethical concerns. The remaining patients received -tocopherol or placebo only. Survival was evaluated by Kaplan-Meier analysis. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. Results: After a median follow-up of 52 months, second primary cancers and recurrences of the first tumor were diagnosed in 113 and 119 participants, respectively. The effect of supplementation on the incidence of second primary cancers varied over time. Compared with patients receiving placebo, patients receiving -tocopherol supplements had a higher rate of second primary cancers during the supplementation period (HR = 2.88, 95% CI = 1.56 to 5.31) but a lower rate after supplementation was discontinued (HR = 0.41, 95% CI = 0.16 to 1.03). Similarly, the rate of having a recurrence or second primary cancer was higher during (HR = 1.86, 95% CI = 1.27 to 2.72) but lower after (HR = 0.71, 95% CI = 0.33 to 1.53) supplementation with -tocopherol. The proportion of participants free of second primary cancer overall after 8 years of follow-up was similar in both arms. Conclusions: -Tocopherol supplementation produced unexpected adverse effects on the occurrence of second primary cancers and on cancer-free survival.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- An Apple a Day...Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention
- Edward S. Kim and Waun Ki Hong
J Natl Cancer Inst 2005 97: 468-470.[Extract] [Full Text] [PDF]
Related Memo to the Media
- Press Release: Antioxidant May Have Adverse Effects in Head and Neck Cancer Patients
- Sarah L. Zielinski
J Natl Cancer Inst 2005 97: 467.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  B. D. Lawenda, J. B. Blumberg, and S. M. Sagar Response: Re: Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? J Natl Cancer Inst, November 5, 2008; 100(21): 1559 - 1560. [Full Text] [PDF]
|
|
|
|
|
|
B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? J Natl Cancer Inst, June 4, 2008; 100(11): 773 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. I. Block An Antioxidant Turnabout Integr Cancer Ther, June 1, 2008; 7(2): 59 - 61. [PDF]
|
|
|
|
 |
|
 S. B. Vuyyuri, D. A. Hamstra, D. Khanna, C. A. Hamilton, S. M. Markwart, K. C.M. Campbell, P. Sunkara, B. D. Ross, and A. Rehemtulla Evaluation of D-Methionine as a Novel Oral Radiation Protector for Prevention of Mucositis Clin. Cancer Res., April 1, 2008; 14(7): 2161 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hopkins, D. W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, et al. Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 490 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Velicer and C. M. Ulrich Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review J. Clin. Oncol., February 1, 2008; 26(4): 665 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Sackett, I. Bairati, F. Meyer, E. Jobin, S. Lussier, A. Fortin, M. Gelinas, A. Nabid, F. Brochet, and B. Tetu Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer Clin. Cancer Res., January 1, 2008; 14(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Moss Do Antioxidants Interfere With Radiation Therapy for Cancer? Integr Cancer Ther, September 1, 2007; 6(3): 281 - 292. [Abstract] [PDF]
|
|
|
|
 |
|
 R. M. Russell The Multifunctional Carotenoids: Insights into Their Behavior J. Nutr., October 1, 2006; 136(10): 2690S - 2692S. [Full Text] [PDF]
|
|
|
|
 |
|
 N. N. Maserejian, E. Giovannucci, B. Rosner, A. Zavras, and K. Joshipura Prospective Study of Fruits and Vegetables and Risk of Oral Premalignant Lesions in Men Am. J. Epidemiol., September 15, 2006; 164(6): 556 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kim, N. Chongviriyaphan, C. Liu, R. M. Russell, and X.-D. Wang Combined antioxidant ({beta}-carotene, {alpha}-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model Carcinogenesis, July 1, 2006; 27(7): 1410 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Moss Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther, March 1, 2006; 5(1): 63 - 82. [Abstract] [PDF]
|
|
|
|
|
|
R. S. Herbst, D. F. Bajorin, H. Bleiberg, D. Blum, D. Hao, B. E. Johnson, R. F. Ozols, G. D. Demetri, P. A. Ganz, M. G. Kris, et al. Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology J. Clin. Oncol., January 1, 2006; 24(1): 190 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. D'Andrea Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided CA Cancer J Clin, September 1, 2005; 55(5): 319 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I-M. Lee, N. R. Cook, J. M. Gaziano, D. Gordon, P. M Ridker, J. E. Manson, C. H. Hennekens, and J. E. Buring Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women's Health Study: A Randomized Controlled Trial JAMA, July 6, 2005; 294(1): 56 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 More Concern About Vitamin E Supplementation Journal Watch Cardiology, June 17, 2005; 2005(617): 5 - 5. [Full Text]
|
|
|
|
 |
|
 More Concern About Vitamin E Supplementation Journal Watch (General), May 3, 2005; 2005(503): 1 - 1. [Full Text]
|
|
|
|
|
|
E. S. Kim and W. K. Hong An Apple a Day...Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention J Natl Cancer Inst, April 6, 2005; 97(7): 468 - 470. [Full Text] [PDF]
|
|